VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Gilead Sciences, Inc. vs London Stock Exchange Group plc
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Gilead Sciences, Inc.
GILD · NASDAQ Global Select Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Gilead Sciences, Inc.'s moat claims, evidence, and risks.
View GILD analysisLondon Stock Exchange Group plc
LSEG · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into London Stock Exchange Group plc's moat claims, evidence, and risks.
View LSEG analysisComparison highlights
- Moat score: both at 74 / 100.
- Segment focus: Gilead Sciences, Inc. has 5 segments (68.5% in HIV); London Stock Exchange Group plc has 5 segments (51% in Data & Analytics).
- Moat breadth: Gilead Sciences, Inc. has 8 moat types across 3 domains; London Stock Exchange Group plc has 8 across 4.
Primary market context
Gilead Sciences, Inc.
HIV
HIV treatment and prevention medicines (antiretroviral therapy and PrEP)
Global (U.S. and Europe are major markets)
Patients/prescribers; reimbursed by public and private payers; distributed via wholesalers and specialty pharmacies
Drug developer and marketing authorization holder
68.5%
London Stock Exchange Group plc
Data & Analytics
Financial market data, analytics and workflows (terminals and enterprise feeds)
Global
Financial institutions and corporates
Data & analytics vendor
51%
Side-by-side metrics
Moat coverage
Shared moat types
Gilead Sciences, Inc. strengths
London Stock Exchange Group plc strengths
Segment mix
Gilead Sciences, Inc. segments
Full profile >HIV
Oligopoly
Oncology (Cell Therapy + Trodelvy)
Oligopoly
Liver Disease
Oligopoly
Veklury (Remdesivir)
Competitive
Other Products
Competitive
London Stock Exchange Group plc segments
Full profile >Data & Analytics
Oligopoly
FTSE Russell
Oligopoly
Risk Intelligence
Oligopoly
Capital Markets
Oligopoly
Post Trade
Quasi-Monopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.